Aarti Pharmalabs Limited (AARTIPHARM) — Announcement | 17 August 2026
No summary available
About Aarti Pharmalabs Limited (AARTIPHARM)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when AARTIPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AARTIPHARM — Free💡 Ask AI about this filing
📊 More AARTIPHARM filings
- 🔴 Announcement — 31 August 2026 Aarti Pharmalabs announced the resignation of Senior General Manager G.M. Naidu effective August 31,...
- 🟡 Sustainability Report — 29 August 2026 Aarti Pharmalabs Limited submitted its Business Responsibility and Sustainability Report for FY 2025...
- 🟡 Board Meeting — 29 August 2026 No summary available
- 🔴 Annual Report — 29 August 2026 No summary available
- 🔴 Financial Results — 10 August 2026 Aarti Pharmalabs Limited reported standalone revenue of **₹5,346 crores** for Q1 FY27, up **42.4% Yo...
🔥 Also filed on 17 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AARTIPHARM files new disclosures
Track AARTIPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AARTIPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd